Literature DB >> 25857825

ALK rearrangement and overexpression in epithelioid fibrous histiocytoma.

Leona A Doyle1, Adrián Mariño-Enriquez1, Christopher D M Fletcher1, Jason L Hornick1.   

Abstract

Epithelioid benign fibrous histiocytoma, also known as 'epithelioid cell histiocytoma,' has traditionally been considered a morphologic variant of cutaneous fibrous histiocytoma (dermatofibroma). In addition to its characteristic epithelioid cytomorphology, several phenotypic differences suggest that epithelioid fibrous histiocytoma may differ biologically from other variants. Recently, ALK rearrangement was described in two cases of epithelioid fibrous histiocytoma and separately in two cases reported as 'atypical' fibrous histiocytoma (with epithelioid features), with corresponding ALK expression detectable by immunohistochemistry. The goals of this study were to determine the frequency of ALK expression by immunohistochemistry in epithelioid fibrous histiocytoma, to determine its value for the diagnosis of epithelioid fibrous histiocytoma among variants and other histologic mimics, and to evaluate ALK gene rearrangement in epithelioid fibrous histiocytoma. ALK protein expression was evaluated in whole tissue sections from 33 epithelioid fibrous histiocytomas, 41 other cases of fibrous histiocytoma (11 conventional and 10 each cellular, atypical, and aneurysmal types), 10 cutaneous syncytial myoepitheliomas, and 5 atypical fibroxanthomas, using a mouse anti-ALK monoclonal antibody. Fluorescence in situ hybridization (FISH) was performed using break-apart probes. In total, 29/33 (88%) cases of epithelioid fibrous histiocytoma showed diffuse cytoplasmic ALK expression. Staining was moderate to strong in intensity in all cases except one, which showed diffuse weak expression. All other tumor types were negative for ALK expression. FISH demonstrated ALK rearrangement in all ALK-immunoreactive cases evaluated (n=13), and not in one ALK expression-negative epithelioid fibrous histiocytoma successfully examined. In conclusion, the majority of epithelioid fibrous histiocytomas demonstrate ALK expression and ALK gene rearrangement. ALK expression is not seen in other variants of fibrous histiocytoma, providing a useful diagnostic tool to distinguish epithelioid fibrous histiocytoma from most histologic mimics. The expression of ALK suggests that epithelioid fibrous histiocytoma is a biologically distinct tumor type, unrelated to conventional fibrous histiocytoma and histologic variants.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25857825     DOI: 10.1038/modpathol.2015.49

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  35 in total

Review 1.  Epithelioid cell histiocytoma: a simulant of vascular and melanocytic neoplasms.

Authors:  E J Glusac; J M McNiff
Journal:  Am J Dermatopathol       Date:  1999-02       Impact factor: 1.533

2.  Metastasizing fibrous histiocytoma of the skin: a clinicopathologic and immunohistochemical analysis of three cases.

Authors:  L Guillou; S Gebhard; M Salmeron; J M Coindre
Journal:  Mod Pathol       Date:  2000-06       Impact factor: 7.842

3.  Atypical fibrous histiocytoma of the skin with CD30 and p80/ALK1 positivity and ALK gene rearrangement.

Authors:  Vanessa Szablewski; Sara Laurent-Roussel; Luc Rethers; Antoine Rommel; Pascal Van Eeckhout; Pascal Vaneechout; Alessandra Camboni; Pascal Willocz; Christiane Copie-Bergman; Nicolas Ortonne
Journal:  J Cutan Pathol       Date:  2014-06-25       Impact factor: 1.587

Review 4.  Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas.

Authors:  Michela Boi; Emanuele Zucca; Giorgio Inghirami; Francesco Bertoni
Journal:  Br J Haematol       Date:  2015-01-06       Impact factor: 6.998

5.  Cell differentiation in benign cutaneous fibrous histiocytomas. An immunohistochemical study with antibodies to histiomonocytic cells and intermediate filament proteins.

Authors:  Y Soini
Journal:  Am J Dermatopathol       Date:  1990-04       Impact factor: 1.533

6.  ALK rearrangement in sickle cell trait-associated renal medullary carcinoma.

Authors:  Adrián Mariño-Enríquez; Wen-Bin Ou; Christopher B Weldon; Jonathan A Fletcher; Antonio R Pérez-Atayde
Journal:  Genes Chromosomes Cancer       Date:  2010-12-13       Impact factor: 5.006

Review 7.  ALK as a paradigm of oncogenic promiscuity: different mechanisms of activation and different fusion partners drive tumors of different lineages.

Authors:  Adrian Mariño-Enríquez; Paola Dal Cin
Journal:  Cancer Genet       Date:  2013-10-03

8.  STAT3 pathway is activated in ALK-positive large B-cell lymphoma carrying SQSTM1-ALK rearrangement and provides a possible therapeutic target.

Authors:  Emanuele S G d'Amore; Carlo Visco; Andrea Menin; Barbara Famengo; Paolo Bonvini; Elena Lazzari
Journal:  Am J Surg Pathol       Date:  2013-05       Impact factor: 6.394

9.  Metastasizing "benign" cutaneous fibrous histiocytoma: a clinicopathologic analysis of 16 cases.

Authors:  Leona A Doyle; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2013-04       Impact factor: 6.394

10.  Ultrastructural aspects of the dermatofibroma.

Authors:  P Candiani; R Rainoldi; M Sideri; C Le Grazie; G De Virgiliis; L Donati
Journal:  Tumori       Date:  1981 May-Jun
View more
  14 in total

1.  Cutaneous Syncytial Myoepithelioma Is Characterized by Recurrent EWSR1-PBX3 Fusions.

Authors:  Vickie Y Jo; Cristina R Antonescu; Brendan C Dickson; David Swanson; Lei Zhang; Christopher D M Fletcher; Elizabeth G Demicco
Journal:  Am J Surg Pathol       Date:  2019-10       Impact factor: 6.394

2.  Cutaneous syncytial myoepithelioma: A recently described neoplasm which may mimic nevoid melanoma and epithelioid sarcoma.

Authors:  Ahmed K Alomari; Noah Brown; Aleodor A Andea; Bryan L Betz; Rajiv M Patel
Journal:  J Cutan Pathol       Date:  2017-08-02       Impact factor: 1.587

Review 3.  A review of kinase fusions in melanocytic tumors.

Authors:  Sara C Shalin
Journal:  Lab Invest       Date:  2016-11-28       Impact factor: 5.662

4.  Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases.

Authors:  Brendan C Dickson; David Swanson; George S Charames; Christopher Dm Fletcher; Jason L Hornick
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

Review 5.  Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themes.

Authors:  Fredrik Mertens; Cristina R Antonescu; Felix Mitelman
Journal:  Genes Chromosomes Cancer       Date:  2015-12-18       Impact factor: 5.006

6.  Intradermal Proliferative Fasciitis Occurring With Chondrodermatitis Nodularis Helicis.

Authors:  Ashley Elsensohn; Sasha Getty; Jessica Shiu; Sébastien de Feraudy
Journal:  Am J Dermatopathol       Date:  2018-02       Impact factor: 1.533

7.  Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile.

Authors:  Steven D Billings; Jennifer S Ko; Josephine K Dermawan; Elizabeth M Azzato; John R Goldblum; Brian P Rubin
Journal:  Mod Pathol       Date:  2021-06-04       Impact factor: 7.842

8.  ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.

Authors:  Paul G Kemps; Jennifer Picarsic; Benjamin H Durham; Zofia Hélias-Rodzewicz; Laura Hiemcke-Jiwa; Cor van den Bos; Marianne D van de Wetering; Carel J M van Noesel; Jan A M van Laar; Robert M Verdijk; Uta E Flucke; Pancras C W Hogendoorn; F J Sherida H Woei-A-Jin; Raf Sciot; Andreas Beilken; Friedrich Feuerhake; Martin Ebinger; Robert Möhle; Falko Fend; Antje Bornemann; Verena Wiegering; Karen Ernestus; Tina Méry; Olga Gryniewicz-Kwiatkowska; Bozenna Dembowska-Baginska; Dmitry A Evseev; Vsevolod Potapenko; Vadim V Baykov; Stefania Gaspari; Sabrina Rossi; Marco Gessi; Gianpiero Tamburrini; Sébastien Héritier; Jean Donadieu; Jacinthe Bonneau-Lagacherie; Claire Lamaison; Laure Farnault; Sylvie Fraitag; Marie-Laure Jullié; Julien Haroche; Matthew Collin; Jackie Allotey; Majid Madni; Kerry Turner; Susan Picton; Pasquale M Barbaro; Alysa Poulin; Ingrid S Tam; Dina El Demellawy; Brianna Empringham; James A Whitlock; Aditya Raghunathan; Amy A Swanson; Mariko Suchi; Jon M Brandt; Nabeel R Yaseen; Joanna L Weinstein; Irem Eldem; Bryan A Sisk; Vaishnavi Sridhar; Mandy Atkinson; Lucas R Massoth; Jason L Hornick; Sanda Alexandrescu; Kee Kiat Yeo; Kseniya Petrova-Drus; Stephen Z Peeke; Laura S Muñoz-Arcos; Daniel G Leino; David D Grier; Robert Lorsbach; Somak Roy; Ashish R Kumar; Shipra Garg; Nishant Tiwari; Kristian T Schafernak; Michael M Henry; Astrid G S van Halteren; Oussama Abla; Eli L Diamond; Jean-François Emile
Journal:  Blood       Date:  2022-01-13       Impact factor: 22.113

9.  Pediatric Mesothelioma With ALK Fusions: A Molecular and Pathologic Study of 5 Cases.

Authors:  Pedram Argani; Derrick W Q Lian; Abbas Agaimy; Markus Metzler; Sara E Wobker; Andres Matoso; Jonathan I Epstein; Yun-Shao Sung; Lei Zhang; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2021-05-01       Impact factor: 6.298

10.  Epithelioid cell histiocytoma with SQSTM1-ALK fusion: a case report.

Authors:  Ryuko Nakayama; Yuki Togashi; Satoko Baba; Yo Kaku; Yuki Teramoto; Takaki Sakurai; Hironori Haga; Kengo Takeuchi
Journal:  Diagn Pathol       Date:  2018-05-10       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.